Deputy: I too feel Gerald could have managed share
Post# of 30028
Posted On: 01/09/2015 4:34:05 PM
Re: Deputy_123 #14627
Deputy: I too feel Gerald could have managed shareholder expectations better than he has. Communication isn't his forte, but building one hell of a Biotech Powerhouse is, though!
This past week as I dug into Nanosomix and the blood test they are rushing to launch at the same time as LymPro, two things became clear to me: 1) Nanosomix was cutting corners, and 2) AMBS was bringing Lympro along the right way. That made me proud of Gerald's tough decisions this past year not to rush Lympro to market before it was ready! Lympro is ready now.
Our expectations were let down last January and July. In January we were trading at .13 cents and didn't get what we wanted and the pps dropped. In July we got up to .193 cents and didn't get what we wanted and the pps dropped. But right now we are trading way down at .08 cents, with Lympro open for business and Retinitis getting an orphan designation, and Eltoprazine and ESS ready to begin clinical trials!! We are in a way different position than we were in back in January and July. We are far stronger than we were, and yet we are trading way lower than we were.
LymPro will soon be embraced by pharmas doing clinical trials and revenue will follow. That will resurrect Gerald's credibility in about 2 minutes!! Anyone not buying down here, if they can, is insane. I even scrounged up a little money and bought 50K shares this morning.
This past week as I dug into Nanosomix and the blood test they are rushing to launch at the same time as LymPro, two things became clear to me: 1) Nanosomix was cutting corners, and 2) AMBS was bringing Lympro along the right way. That made me proud of Gerald's tough decisions this past year not to rush Lympro to market before it was ready! Lympro is ready now.
Our expectations were let down last January and July. In January we were trading at .13 cents and didn't get what we wanted and the pps dropped. In July we got up to .193 cents and didn't get what we wanted and the pps dropped. But right now we are trading way down at .08 cents, with Lympro open for business and Retinitis getting an orphan designation, and Eltoprazine and ESS ready to begin clinical trials!! We are in a way different position than we were in back in January and July. We are far stronger than we were, and yet we are trading way lower than we were.
LymPro will soon be embraced by pharmas doing clinical trials and revenue will follow. That will resurrect Gerald's credibility in about 2 minutes!! Anyone not buying down here, if they can, is insane. I even scrounged up a little money and bought 50K shares this morning.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼